All Comments by Reisa Sperling
- New Data from Past BACE Inhibitor Trials Shed Light on Side Effects
- Coronavirus Takes Its Toll on Alzheimer’s Clinical Studies
- Colleagues Mourn Loss of Rahul Desikan, Age 41, to ALS
- BAN2401 Removes Brain Amyloid, Possibly Slows Cognitive Decline
- Selecting Trial Participants Based on Tangle Pathology Might Improve Power
- Gammagard™ Misses Endpoints in Phase 3 Trial
- FDA Invites Comment on Drug Testing Guidance for Early AD
- FDA Approves Amyvid for Clinical Use
- Testing the right target and right drug at the right stage.
- An Operational Approach to NIA-AA Criteria for Preclinical Alzheimer’s Disease.
- What Do Clinicians Say? Peers Welcome Revised Criteria
- BOLD New Look—Aβ Linked to Default Network Dysfunction